I agree that this site is using cookies. You can find further informations here.
X
Cabré, E.
365  results:
Search for persons X
?
1

P495 Spacing the administration interval of anti-TNF agents..:

Torres, P ; Núñez, L ; Aguilar, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S359-S360 , 2019
Link: https://doi.org/10.1093/..
 
?
2

P424 Is the switch to a second thiopurine a safe strategy i..:

Calafat, M ; Mañosa, M ; Ricart, E...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S321-S322 , 2019
Link: https://doi.org/10.1093/..
 
?
3

P345 Risk of long-term post-operative recurrence (POR) in C..:

Mañosa, M ; Puig, M ; Torres, P F...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S275-S275 , 2019
Link: https://doi.org/10.1093/..
 
?
4

P663 Primary prevention of post-operative recurrence of Cro..:

Cañete, F ; Mañosa, M ; Casanova, M J...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S445-S446 , 2018
Link: https://doi.org/10.1093/..
 
?
5

N032 Impact of pain due to subcutaneous administration of a..:

Gely, C ; Marin, L ; Gordillo, J...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S582-S583 , 2018
Link: https://doi.org/10.1093/..
 
?
6

P609 Uncertain usefulness of infliximab trough levels for t..:

Cañete, F ; Lobatón, T ; Cabré, E...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S417-S417 , 2018
Link: https://doi.org/10.1093/..
 
?
7

ANP32E, a Protein Involved in Steroid-Refractoriness in Ulc..:

Lorén, V ; Garcia-Jaraquemada, A ; Naves, J E...
Journal of Crohn's and Colitis.  13 (2018)  3 - p. 351-361 , 2018
Link: https://doi.org/10.1093/..
 
?
8

P631 Treatment of established post-operative recurrence of ..:

Cañete, F ; Mañosa, M ; Barreiro-de Acosta, M...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S428-S429 , 2018
Link: https://doi.org/10.1093/..
 
?
9

P367 The availability of infliximab trough levels in IBD pa..:

Lobaton, T. ; Cañete, F. ; Teniente, A....
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S265-S265 , 2017
Link: https://doi.org/10.1093/..
 
?
10

P480 Characteristics of drug-induced lupus 2° to anti-TNF a..:

Mañosa, M. ; Corrales, G. ; Olivares, D....
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S323-S323 , 2017
Link: https://doi.org/10.1093/..
 
?
11

P562 Real-life infliximab trough levels among inflammatory ..:

Lobaton, T. ; Cañete, F. ; Teniente, A....
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S366-S367 , 2017
Link: https://doi.org/10.1093/..
 
?
12

DOP013 Pre-treatment differential microRNA expression profi..:

Naves, J.E. ; Mañe, J. ; Loren, V....
Journal of Crohn's and Colitis.  8 (2014)  - p. S20-S21 , 2014
Link: https://doi.org/10.1016/..
 
?
13

DOP081 Long-term natural history of postoperative recurrenc..:

Mañosa, M. ; Zabana, Y. ; Marin, L....
Journal of Crohn's and Colitis.  8 (2014)  - p. S54 , 2014
Link: https://doi.org/10.1016/..
 
?
14

HLA‐DQ2/DQ8 and HLA‐DQB1*02 homozygosity typing by real‐tim..:

Ruiz‐Ortiz, E. ; Montraveta, M. ; Cabré, E....
Tissue Antigens.  84 (2014)  6 - p. 545-553 , 2014
Link: https://doi.org/10.1111/..
 
?
15

DOP051 Usefulness of a faecal calprotectin rapid semiquanti..:

Garcia-Planella, E. ; Manyosa, M. ; Chaparro, M....
Journal of Crohn's and Colitis.  8 (2014)  - p. S39 , 2014
Link: https://doi.org/10.1016/..
 
1-15